|
Outgoing
|
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
is a
EC 1.14.13.* (oxidoreductase acting on paired donors, incorporating 1 atom of oxygen, with NADH or NADPH as one donor) inhibitor
(CHEBI:76841)
|
|
|
Incoming
|
(−)-demethoxylpinoresinol
(CHEBI:65738)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
(2R*,3R*)-2,3-dihydro-7-hydroxy-2,3-dimethyl-2-[4,8-dimethyl-3(E)-7-nonadien-6-onyl]furo[3,2-c]coumarin
(CHEBI:65928)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
(2S*,3R*)-2,3-dihydro-7-hydroxy-2,3-dimethyl-2-[4,8-dimethyl-3(E),7-nonadien-6-onyl]-furo[3,2-c]coumarin
(CHEBI:65929)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
(2S*,3R*)-2,3-dihydro-7-methoxy-2,3-dimethyl-2-[4-methyl-5-(4-methyl-2-furyl)-3(E)-pentenyl]-furo[3,2-c]coumarin
(CHEBI:65930)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
(RS)-mallotophilippen E
(CHEBI:66659)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
1-(4'-hydroxy-3'-methoxyphenyl)-7-phenyl-3-heptanone
(CHEBI:66033)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
1-O-acetyl-4R,6S-britannilactone
(CHEBI:65365)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
3-O-methyl-isosecotanapartholide
(CHEBI:66090)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
4-hydroxycinnamaldehyde
(CHEBI:28353)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
5-hydroxyzerumbone
(CHEBI:66050)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
6-propyl-2-thiouracil
(CHEBI:8502)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
N-[3-(aminomethyl)benzyl]acetamidine
(CHEBI:90721)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
Nγ-nitro-L-arginine methyl ester
(CHEBI:7549)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
Nγ-nitro-L-arginine methyl ester hydrochloride
(CHEBI:131182)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
Nω,N'ω-dimethyl-L-arginine
(CHEBI:25682)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
Nω,Nω-dimethyl-L-arginine
(CHEBI:17929)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
N6-acetimidoyl-L-lysine dihydrochloride
(CHEBI:63964)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
S-methyl-L-thiocitrulline
(CHEBI:90712)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
L-citrulline
(CHEBI:16349)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
L-glutamine
(CHEBI:18050)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
ainsliadimer A
(CHEBI:65376)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
aminoguanidine
(CHEBI:40618)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
bis(7)-tacrine
(CHEBI:138435)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
dihydroxanthohumol
(CHEBI:66332)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
formamidine
(CHEBI:38477)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
fukanefuromarin A
(CHEBI:65921)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
fukanefuromarin B
(CHEBI:65922)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
fukanefuromarin C
(CHEBI:65923)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
fukanefuromarin D
(CHEBI:65924)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
fukanefuromarin E
(CHEBI:65925)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
fukanefuromarin F
(CHEBI:65926)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
fukanefuromarin G
(CHEBI:65927)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
fukanemarin A
(CHEBI:65919)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
fukanemarin B
(CHEBI:65920)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
futokadsurin A
(CHEBI:65936)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
futokadsurin B
(CHEBI:65937)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
futokadsurin C
(CHEBI:65938)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
indicanone
(CHEBI:66072)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
isosecotanapartholide
(CHEBI:66089)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
mallotophilippen A
(CHEBI:66655)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
mallotophilippen B
(CHEBI:66656)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
mallotophilippen C
(CHEBI:66657)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
mallotophilippen D
(CHEBI:66658)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
methyl propenyl ketone
(CHEBI:89540)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
methylguanidine
(CHEBI:16628)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
myricitrin
(CHEBI:70082)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
nitroflurbiprofen
(CHEBI:77428)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
oroxylin A
(CHEBI:61668)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
oroxylin A(1−)
(CHEBI:77939)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
oxygenated xanthohumol
(CHEBI:66333)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
paraminabeolide A
(CHEBI:67560)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
paraminabeolide B
(CHEBI:67561)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
paraminabeolide C
(CHEBI:67562)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
paraminabeolide D
(CHEBI:67563)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
phoyunbene A
(CHEBI:66753)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
phoyunbene B
(CHEBI:66754)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
phoyunbene C
(CHEBI:66755)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
phoyunbene D
(CHEBI:66756)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
thienodolin
(CHEBI:9543)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
triptoquinone A
(CHEBI:132352)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
xanthohumol B
(CHEBI:66334)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
xanthohumol D
(CHEBI:66335)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
zaluzanin C
(CHEBI:10103)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
zerumboneoxide
(CHEBI:66502)
has role
EC 1.14.13.39 (nitric oxide synthase) inhibitor
(CHEBI:61908)
|
|
EC 1.14.13.39 (nitric oxide synthase) inhibitors
|
ChEBI
|
|
EC 1.14.13.39 inhibitor
|
ChEBI
|
|
EC 1.14.13.39 inhibitors
|
ChEBI
|
|
endothelium-derived relaxation factor-forming enzyme inhibitor
|
ChEBI
|
|
endothelium-derived relaxation factor-forming enzyme inhibitors
|
ChEBI
|
|
endothelium-derived relaxing factor synthase inhibitor
|
ChEBI
|
|
endothelium-derived relaxing factor synthase inhibitors
|
ChEBI
|
|
NADPH-diaphorase inhibitor
|
ChEBI
|
|
NADPH-diaphorase inhibitors
|
ChEBI
|
|
nitric oxide synthase (EC 1.14.13.39) inhibitor
|
ChEBI
|
|
nitric oxide synthase (EC 1.14.13.39) inhibitors
|
ChEBI
|
|
nitric oxide synthase inhibitor
|
ChEBI
|
|
nitric oxide synthase inhibitors
|
ChEBI
|
|
nitric oxide synthetase inhibitor
|
ChEBI
|
|
nitric oxide synthetase inhibitors
|
ChEBI
|
|
nitric-oxide synthetase inhibitor
|
ChEBI
|
|
nitric-oxide synthetase inhibitors
|
ChEBI
|
|
NO synthase inhibitor
|
ChEBI
|
|
NO synthase inhibitors
|
ChEBI
|
